2m 2m 2m 2m 2m 2m 2m
Veracyte (VCYT)
NASDAQ
$40.87-$0.005 (-0.01%)
Price as of Sep 11, 2026 7:30 PM EDT- $3.3BMarket Cap
- 32.35%1-Year Change
- Diagnostics & ResearchIndustry
Veracyte (VCYT)
$40.87-$0.005 (-0.01%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
BLACKROCK, INC. | 16.90% | 13.5M | +313,819 (+2.33%) | Jun 30, 2026 |
VANGUARD GROUP INC | 10.66% | 8.5M | -77 (-0.0009%) | Dec 31, 2025 |
BLACKROCK INC. | 9.77% | 7.8M | +581,688 (+7.46%) | Jun 30, 2024 |
FMR LLC | 9.65% | 7.7M | -61,103 (-0.79%) | Jun 30, 2026 |
BLACKROCK FUNDING, INC. /DE | 9.43% | 7.5M | -111,686 (-1.48%) | Dec 31, 2024 |
ARTISAN PARTNERS LIMITED PARTNERSHIP | 6.94% | 5.5M | +42,034 (+0.76%) | Jun 30, 2026 |
WELLINGTON MANAGEMENT CO LLP | 6.37% | 5.1M | +9,476 (+0.19%) | Dec 31, 2021 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
iSHARES TRUST | 11.33% | 9.0M | +323,851 (+3.58%) | Jun 30, 2026 |
VANGUARD INDEX FUNDS | 7.94% | 6.3M | +81,837 (+1.29%) | Jun 30, 2026 |
Ark ETF Trust | 3.46% | 2.8M | -575,065 (-20.83%) | Apr 30, 2026 |
SPDR SERIES TRUST | 3.38% | 2.7M | -409,015 (-15.17%) | Jun 30, 2026 |
FIRST TRUST EXCHANGE-TRADED FUND | 3.06% | 2.4M | +522,844 (+21.42%) | Jun 30, 2026 |
FIDELITY SELECT PORTFOLIOS | 2.86% | 2.3M | +192,294 (+8.43%) | May 31, 2026 |
VANGUARD EXPLORER FUND | 2.22% | 1.8M | +293,103 (+16.56%) | Apr 30, 2026 |
Current Ownership Distribution
- Institutions1.6B (73.35%)
- Mutual Funds555.6M (26.29%)
- Insiders7.7M (0.36%)
- Other0 (0.00%)
Insider Transactions
- 0.36% (7.7M)Current InsiderOwnership (%, shares)
- 0Number of InsiderBuying (last 12 months)
- $0.00Amount of InsiderBuying (last 12 months)
- 11Number of InsiderSelling (last 12 months)
- $136.2MAmount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
Febbo Phillip G. Chief Scientific & Med Officer | Sell | Sep 04, 2026 | $446,304.79 | 10,405 | $42.89 | 135,753 |
McGuire Annie EVP, General Counsel | Sell | Sep 04, 2026 | $92,173.11 | 2,154 | $42.79 | 132,260 |
Chambers Rebecca Chief Financial Officer | Sell | Sep 04, 2026 | $106,030.21 | 2,477 | $42.81 | 167,200 |
McGuire Annie EVP, General Counsel | Sell | Sep 04, 2026 | $48,038.98 | 1,100 | $43.67 | 131,160 |
Febbo Phillip G. Chief Scientific & Med Officer | Sell | Sep 04, 2026 | $118,105.17 | 2,705 | $43.66 | 133,048 |
Chambers Rebecca Chief Financial Officer | Sell | Sep 04, 2026 | $51,363.95 | 1,175 | $43.71 | 166,025 |
Stapley Marc Chief Executive Officer | In Kind | Sep 02, 2026 | $394,136.16 | 8,782 | $44.88 | 432,073 |
Febbo Phillip G. Chief Scientific & Med Officer | In Kind | Sep 02, 2026 | $163,318.32 | 3,639 | $44.88 | 146,158 |
Wygant Jonathan VP, Chief Accounting Officer | In Kind | Sep 02, 2026 | $61,081.68 | 1,361 | $44.88 | 43,226 |
Chambers Rebecca Chief Financial Officer | In Kind | Sep 02, 2026 | $161,702.64 | 3,603 | $44.88 | 169,677 |
McGuire Annie EVP, General Counsel | In Kind | Sep 02, 2026 | $144,289.20 | 3,215 | $44.88 | 134,414 |
Bhanji Muna | Sell | Sep 01, 2026 | $80,096.08 | 1,864 | $42.97 | 42,718 |
EASTHAM KARIN | Sell | Jun 18, 2026 | $168,906.24 | 3,200 | $52.78 | 15,626 |
EASTHAM KARIN | Sell | Jun 18, 2026 | $28,328.16 | 529 | $53.55 | 15,097 |
EASTHAM KARIN | Award | Jun 11, 2026 | $0.00 | 5,272 | $0.00 | 18,826 |
Barr Eliav | Award | Jun 11, 2026 | $0.00 | 5,272 | $0.00 | 56,461 |
Shafer David Brent | Award | Jun 11, 2026 | $0.00 | 5,272 | $0.00 | 31,100 |
JONES EVAN/ FA | Award | Jun 11, 2026 | $0.00 | 5,272 | $0.00 | 34,634 |
Bhanji Muna | Award | Jun 11, 2026 | $0.00 | 5,272 | $0.00 | 44,582 |
Miller Thomas F. | Award | Jun 11, 2026 | $0.00 | 5,272 | $0.00 | 31,100 |
McGuire Annie SVP, General Counsel | Award | Mar 06, 2026 | $0.00 | 32,892 | $0.00 | 127,598 |
Wygant Jonathan VP, Chief Accounting Officer | Award | Mar 06, 2026 | $0.00 | 10,525 | $0.00 | 45,434 |
McGuire Annie SVP, General Counsel | Award | Mar 06, 2026 | $0.00 | 26,314 | $0.00 | 153,912 |
Leite John Chief Commercial Officer-CLIA | Award | Mar 06, 2026 | $0.00 | 36,181 | $0.00 | 143,761 |
Febbo Phillip G. Chief Scientific & Med Officer | Award | Mar 06, 2026 | $0.00 | 29,603 | $0.00 | 146,949 |
Leite John Chief Commercial Officer-CLIA | Award | Mar 06, 2026 | $0.00 | 6,578 | $0.00 | 150,339 |
Febbo Phillip G. Chief Scientific & Med Officer | Award | Mar 06, 2026 | $0.00 | 6,578 | $0.00 | 153,527 |
Stapley Marc Chief Executive Officer | Sell | Mar 04, 2026 | $684,226.19 | 19,244 | $35.56 | 383,833 |
Chambers Rebecca Chief Financial Officer | Sell | Mar 04, 2026 | $156,409.44 | 4,400 | $35.55 | 145,137 |
Stapley Marc Chief Executive Officer | Sell | Mar 04, 2026 | $953,367.96 | 26,279 | $36.28 | 357,554 |